Responses
Abstracts accepted for publication
Cytokines and inflammatory mediators
AB0057 Soluble pd-1 and spd-l2 are unaffected by adalimumab treatment in early ra and associated with presence of anti-ccp and igm-rf
Compose a Response to This Article
Other responses
No responses have been published for this article.